Irreversible Steroidal Aromatase Inactivator (Type I AI)
Dragon Pharma Aromasin 25 mg, containing the active pharmaceutical ingredient Exemestane, represents a distinct and powerful class of estrogen control therapy: the irreversible steroidal aromatase inactivator. For bodybuilders and athletes engaged in cycles with aromatizing anabolic steroids, managing estrogen is a critical component of success, health, and avoiding debilitating side effects. Exemestane operates through a unique "suicide inhibition" mechanism—it permanently binds to and deactivates the aromatase enzyme, the very catalyst that converts androgens like testosterone into estrogen. This irreversible action differentiates it from non-steroidal inhibitors like Anastrozole (Arimidex) and provides a profound, long-lasting suppression of estrogen production, making it a top-tier choice for both on-cycle management and integrated Post Cycle Therapy (PCT) protocols.
Manufactured to exacting pharmaceutical standards in Dragon Pharma's certified European facilities, each 25 mg tablet delivers a precise dose of Exemestane. Its steroidal backbone not only facilitates its irreversible binding but also imparts very mild androgenic properties, which may offer a slight anabolic buffer not present with other AIs. The clinical result is a dramatic reduction in serum estradiol levels, effectively preventing and reversing estrogenic side effects such as gynecomastia, severe water retention (bloat), and related high blood pressure. By stripping away estrogen-driven subcutaneous water, Aromasin delivers a visibly harder, drier, and more vascular physique, allowing for true muscle definition to shine through.
CRITICAL PHARMACOLOGICAL CONSIDERATION: While highly effective, Exemestane's potency comes with significant considerations. Its impact on lipid profiles is more pronounced than other AIs, notably in reducing protective HDL cholesterol, which necessitates vigilant cardiovascular monitoring and support. Furthermore, its irreversible action means that dosing must be precise and conservative; crashing estrogen levels leads to severe joint pain, low libido, mood disturbances, and potential bone density loss over time. Responsible use mandates starting with the lowest effective dose (often 12.5 mg every other day) and adjusting based on symptoms or, ideally, blood work to maintain estradiol in a healthy range (20-30 pg/mL).
Key Benefits:
Each sachet contains 100 tablets of 25mg Exemestane, manufactured under strict quality control standards in Dragon Pharma's certified facilities.
| Product Name | Aromasin 25 mg |
| Manufacturer | Dragon Pharma |
| Substance | Exemestane |
| Packaging | 100 tablets in sealed sachet |
| Lab Test Result | 24.21 mg (Sep 2025) - Verified dosage |
| Half-Life | Approximately 27 hours |
| Recommended Use | On-cycle estrogen control / PCT support |
| Form | Oral tablet |
| AI Type | Type I - Irreversible Steroidal Inactivator |
| Standard Dosage (Men) | 12.5 - 25 mg every other day (adjust per need) |
Guiding Principle: Due to its irreversible action, Exemestane has a cumulative effect. Start with a low dose and increase only if necessary. Splitting the 25 mg tablet is common. Always prioritize symptom management and blood work over fixed schedules.
The most significant management point is for cholesterol. Exemestane is notoriously harsh on lipids. It is imperative to support cardiovascular health with a diet low in saturated fats, high in fiber, and supplemented with high-dose Omega-3 fatty acids, niacin, and plant sterols. Regular cardio is essential. For joint pain associated with low estrogen, consider supplements like glucosamine, chondroitin, and peptides such as BPC-157. If side effects become severe, reduce the dose immediately.
While not hepatotoxic like some oral steroids, the cardiovascular strain from altered lipids is the primary concern. Beyond diet and cardio, consider supplements like CoQ10 and Hawthorne Berry for general cardiovascular support. Regular blood work monitoring lipid panels (Total Cholesterol, HDL, LDL, Triglycerides) and liver enzymes (ALT, AST) is non-negotiable for any responsible user, especially when using exemestane for extended periods.
Note: The independent third-party lab test dated September 2, 2025, confirms a potency of 24.21 mg of Exemestane per tablet. This result, very close to the 25 mg label claim, verifies Dragon Pharma's commitment to accurate dosing and product consistency, ensuring you receive a reliable and potent aromatase inactivator for precise estrogen control.
Proper storage is essential to maintain the chemical stability of Exemestane tablets.
Exemestane is a steroidal aromatase inactivator (Type I AI). Unlike reversible inhibitors, it binds irreversibly to the aromatase enzyme, permanently deactivating it through a process called 'suicide inhibition.' This means the body must synthesize new enzyme molecules to restore estrogen production, leading to a prolonged suppression even after the drug is cleared. It reduces total-body estrogen production by ~85-95%, effectively lowering serum estradiol levels. This action is crucial for countering the effects of excess estrogen that arise from the aromatization of anabolic steroids.
For male athletes on cycles with aromatizing compounds (like testosterone, Dianabol, or Deca), Aromasin serves two primary functions:
The most severe side effects are related to excessively suppressed estrogen (hypoestrogenism). These include a significant negative impact on cholesterol profiles—substantially lowering protective HDL (good) cholesterol and potentially raising LDL. This increases long-term cardiovascular risk. Other serious effects can include severe joint pain, loss of bone mineral density (osteoporosis) with prolonged use, significant mood disturbances (depression, irritability), loss of libido, and erectile dysfunction. Unlike non-steroidal AIs, exemestane has weak androgenic activity, which may contribute to androgenic side effects like hair loss or acne in predisposed individuals.
No, exemestane does not cause fat gain. In fact, its primary aesthetic effect in bodybuilding is significant weight loss from water, as it eliminates estrogen-driven water retention. Users typically experience a noticeable drop in subcutaneous water, leading to a leaner, tighter, and more vascular appearance. The concern with weight is related to bone health, not fat. Long-term, high-dose use can contribute to bone density loss (osteoporosis), potentially increasing fracture risk. The perceived 'weight loss' is almost entirely from fluid, not fat tissue.
The key differences are:
Selective Estrogen Receptor Modulator (SERM)
Long-Acting Testosterone Ester - The #1 Steroid Base
Selective Estrogen Receptor Modulator (SERM)
Official distributor of Dragon Pharma products. Pharmaceutical grade research compounds shipped worldwide.
USA Domestic: 4-5 business days
International: 13-15 business days
Important Disclaimer: All products sold on this website are for research purposes only. They are not intended for human consumption or diagnostic use. These products are not drugs and are not approved by the FDA for the treatment, cure, or prevention of any disease or condition. By purchasing from our store, you acknowledge that you are a qualified researcher and understand the proper handling procedures for these compounds. Keep all products out of reach of children and unauthorized persons.
© 2009 - 2026 Dragon Pharma™. All rights reserved.